A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE). (Q46055629)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE). |
scientific article |
Statements
1 reference
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE). (English)
1 reference
Joan T Merrill
1 reference
Kenneth C Kalunian
1 reference
Romeo Maciuca
1 reference
Jacqueline M McBride
1 reference
Michael J Townsend
1 reference
Xiaohui Wei
1 reference
John C Davis
1 reference
William P Kennedy
1 reference
2 June 2015
1 reference
75
1 reference
1
1 reference
196-202
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference